This inventor holds 5 USPTO granted patents. Top assignees: Abbott Laboratories Corporation, Basf Aktiengesellschaft, Knoll Aktiengesellschaft. Active years: 1993-2002.
Location History:
- Speyer, DE (1993)
- Mannheim, DE (1994 - 2002)
Company Filing History:
2 out of 4,186 
2 out of 10,816 
1 out of 84 Years Active: 1993-2002
Title: Michael Kirchengast: Innovator in Pharmaceutical Combinations
Introduction
Michael Kirchengast is a notable inventor based in Mannheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of combined preparations for controlling diseases. With a total of 5 patents, his work has had a meaningful impact on medical treatments.
Latest Patents
Among his latest patents, Kirchengast has developed an endothelin antagonist and beta receptor blocking agent as combined preparations. This innovative combination is designed to effectively control various diseases. Additionally, he has patented a combination of endothelin antagonists and renin-angiotensin system inhibitors, which also serves to manage disease conditions effectively.
Career Highlights
Throughout his career, Michael Kirchengast has worked with prominent companies such as Abbott Laboratories Corporation and BASF Aktiengesellschaft. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations.
Collaborations
Some of his notable coworkers include Klaus Münter and Wilfried Lubisch. Their collaborative efforts have contributed to the advancement of his research and patent developments.
Conclusion
Michael Kirchengast's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to influence the development of effective medical treatments.